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Background: In the U.S., the number of hospitalized patients diagnosed with a substance use 
disorder (SUD; e.g., opioid use disorder, alcohol use disorder) is growing at an alarming rate. 
Often negatively impacted by stigma, homelessness and physical and mental comorbidities, this 
vulnerable patient population may benefit from the use of hospital-based harm reduction 
interventions (HHRIs) to improve overall hospital care experiences and negative health 
outcomes.  
Purpose: To examine how harm reduction principles have been successfully applied to HHRIs 
resulting in decreased negative health outcomes associated with SUD, improved healthcare 
provider-patient relationships, and reduced financial burden of healthcare systems. 
Methods: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines 
and flow diagram were utilized for this systematic review. Nineteen studies met the eligibility 
criteria for inclusion in the review.  
Implications: Four consistent themes that either inhibit or facilitate the implementation of 
HHRIs (e.g., establishing specialized SUD hospital units, employing peer support specialists, 
utilizing the clinical opiate withdrawal scale) were identified: ethical responsibility, stigma, 
structural changes to hospital systems, and noted gaps associated with post-discharge care.  
Conclusion: HHRIs are a useful treatment option to manage the unique needs associated with the 
growing SUD patient population.  
Keywords: Harm reduction, substance use disorder, SUD, opioid use disorder, OUD, acute care 
hospital 
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Harm reduction is defined as “interventions aimed at reducing the negative effects of 
health behaviors without necessarily extinguishing the problematic health behaviors completely 
or permanently” (Hawk et al., 2017, p. 1). The evidence-based and cost-effective practices of 
harm reduction can easily be applied to acute care hospital settings. An estimated 15% of 
patients in an acute care hospital have a substance use disorder (SUD), and often require cost-
intensive, sometimes onerous, healthcare-related interventions (Trowbridge et al., 2017). In 
addition, this patient population is commonly discharged from the hospital against medical 
advice (AMA) leading to further negative health consequences (Ti & Ti, 2015).  
The purpose of this review is to not only define harm reduction but examine how its 
principles have been successfully applied to hospital-based harm reduction interventions 
(HHRIs) resulting in decreased negative health outcomes associated with SUD, improved 
healthcare provider-patient relationships, and reduced financial burden of healthcare systems. 
The focus will be a systematic review on the utilization of harm reduction interventions within 
acute care hospitals furthering the discussion on HHRIs strengths, limitations, and 




The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
guidelines and flow diagram (see Appendix A) were utilized for this systematic review (Moher et 
al., 2009).   
 
Search Strategy  
 
The following three databases were utilized to identify applicable studies found in peer-
reviewed journals from 2010 to 2021: CINAHL Complete, PubMed, and Google Scholar. The 
following keywords were consistently used for each database: “harm reduction,” “hospital,” 
“acute care,” “addiction consult services,” and “substance use disorder.” Case reports were not 
excluded, but acknowledged, due to the burgeoning nature of the subject. A hand searching (a 
methodological process that includes, but is not limited to, searching journal content, and 
references lists for relevant articles that may have been missed during the initial database 
searches) of reference lists of published studies yielded relevant works that were included in the 
review. Studies were restricted to the English language and adult populations.  
 
Inclusion and Exclusion Criteria 
Studies were included if they were published in peer-reviewed journals. Original studies 
were retained if they included harm reduction interventions for acute care patients with SUD as a 
broad diagnosis or a more specific diagnosis (e.g., opioid use disorder [OUD], alcohol use 
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disorder [AUD], stimulant use disorder). Due to the interest of harm reduction interventions 
within the acute care hospitals, studies were excluded if the reported setting was a clinic (e.g., 
safe injection site, urgent care, primary care office), psychiatric hospital, emergency department, 
or drug and alcohol treatment facility. Grey literature (e.g., preliminary progress reports, theses, 




Database and manual searching identified 58 potentially eligible studies: PubMed (n=19), 
CINAHL Complete (n=7), Google Scholar (n=12), and other sources (n=20). After duplicate 
studies were excluded, 44 screened studies were available for analysis; six articles were 
excluded, based on the aforementioned criteria, which yielded 38 full-text studies. Nineteen full-
text studies were ineligible for inclusion based on the wrong setting and/or wrong harm reduction 
intervention (e.g., syringe service program). In total, 19 studies published between 2010-2021 
met the eligibility criteria for inclusion in the systematic review (see Appendix B). 
Eighteen of the studies were conducted in the United States or Canada; one was 
conducted in Australia. Most of the studies (n= 13, [68%]) included SUD patients within their 
sample population, two of the articles only included health care providers (e.g., physicians, 
nurses, physician assistants, other staff) in their sample population, and two of the studies 
included both health care providers and SUD patients. HHRIs comprised of a supervised 
inhalation room (n=1), addiction consultation services (n=7), patient-centered care (PCC; [n=3]), 
motivational interviewing (MI; [n=2]), opioid agonist therapy or medication for treatment (MFT; 
[n=1]), multidisciplinary discharge planning (n=5), and generalized harm reduction and barriers 
to implementation (n=3).  
One study examined the cost of treatment for infections related to SUD, and harm 
reduction interventions to decrease this cost. Other studies (n=2) examined the phenomena of 
SUD patients leaving the acute care hospital AMA, the negative health outcomes associated 
leaving AMA, and what harm reduction interventions are associated with decreasing AMA 
discharges. Most of the eligible studies were qualitative inquiries (n=5) and cohort studies (n=5). 
Followed by systematic reviews (n=2), cross sectional study (n=1), mixed method study (n=1), 
random controlled trial (n=1), case control study (n=1), and quasi-experimental design (n=1). 




The design and implementation of complex HHRIs can be guided by two conceptual 
frameworks: the harm reduction model and The Consolidated Framework for Implementation 
Research (CFIR).  
 
Harm Reduction Model 
 
The harm reduction model was first defined by the World Health Organization (WHO)  
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in 1973 (Ball, 2007). The concept of harm reduction propounded an alternative to the well-
established models of treatment for SUD: the moral model (illicit drug consumption is immoral 
and deserved of criminal punishment), and the disease model (SUD is a biological disease 
emphasizing abstinence-based treatments; Marlatt, 1996). Harm reduction model is “based on 
public-health principles and...offers a pragmatic yet compassionate set of principles and 
procedures designed to reduce the harmful consequences of addictive behavior for both drug 
consumers and for the society in which they live” (Marlatt, 1996, p. 779). The primary goal of 
harm reduction is to decrease the mortality rate of people living with SUD (Harm Reduction 
International [HRI], 2009).   
The objectives of the harm reduction model provide an upstream approach for SUD 
advocacy and are guided by these six principles: humanism, pragmatism, individualism, 
autonomy, incrementalism, and accountability without termination (Hawk et al., 2017). In the 
context of the acute care hospital setting, the principles of the harm reduction model aim to 
reduce the negative health effects of drug and alcohol use by: (a) emphasizing individualized 
care practices and positive reinforcement; (b) stressing the importance of understanding the root 
causes of SUD for appropriate multidisciplinary, psychosocial interventions; (c) treating people 
with SUD compassionately and respectfully while avoiding stigma; (d) abstinence-based 
practices are never prioritized; and (e) involving patients with SUD in every aspect of their care 
(Harm Reduction International [HRI], n.d.; Hawk et al., 2017).   
 
The CFIR 
Developed by Damschroder et al. (2009), the CFIR was “developed to guide systematic 
assessment of multilevel implementation contexts to identify factors that might influence 
intervention implementation and effectiveness” (Keith et al., 2017, p. 2). The domains and 
constructs of The CFIR can be used as tools of implementation and evaluation of a HHRI by 
identifying internal and external factors which influence processes and polices, analyzing and 
simplifying these processes to help reach an outcome, and organizing the findings to evaluate the 
outcomes (Breimaier et al., 2015; Keith et al., 2017). 
The CFIR’s domains and relevant constructs include: (a) intervention characteristics 
(e.g., key hospital stakeholders’ perceptions of intervention, cost associated with intervention, 
and complexity); (b) outer setting, or external factors influencing implementation of intervention 
(e.g., U.S. cultural ideas on harm reduction interventions and public policies); (c) inner setting, 
or internal factors influencing implementation of intervention (e.g., hospital or ward culture 
surrounding harm reduction, stigmatization of SUD patients, and hospital-specific policies to 
implement intervention); (d) characteristics of individuals (e.g., hospital staff’s knowledge about 
the intervention and readiness for change); and (e) process (e.g., engagement of key hospital 
stakeholders with planning and implanting the intervention through education, reflecting, and 
evaluation; (Damschroder et al., 2009; Keith et al., 2017).  
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Literature Review 
Present-day harm reduction strategies originated from 18th and 19th century European 
colonies in Asia where harm reduction principles aided those suffering from addiction to alcohol 
and opium, and 20th century British doctors who prescribed heroin and morphine to those with 
OUD (Ball, 2007). In the United States, early 20th century drug policies were influenced by 
abstinence-based practices and ideologies which emphasized drug control through 
criminalization of people with a SUD. In the 1960s, these abstinence-based laws and healthcare 
practices were contested with the introduction of medication for treatment (MFT; i.e., methadone 
programs) to treat patients with OUD (Ball, 2007). 
 
Background    
In the U.S., an estimated 22 million people have a SUD (Wakeman et al., 2017) which 
includes AUD, OUD, and/or stimulant use disorder. Adults with a SUD are often negatively 
impacted by social determinants of health (e.g., stigma, homelessness, poverty, lack of available 
community-based healthcare services); as well as physical and mental comorbidities which 
render them vulnerable to negative health outcomes (Cortina et al., 2018). This population is 
more susceptible to skin and soft tissue infections, bacteremia or sepsis, endocarditis, 
osteomyelitis, hepatitis B virus, hepatitis C virus, and HIV (human immunodeficiency virus) 
infections (Capizzi et al., 2020; McNeil et al., 2016; Velez et al., 2016). Due to an increase in 
morbidity rates and a 13.8-year decrease in life expectancy amongst people with a SUD 
(Trowbridge et al., 2017), inpatient hospitalizations and emergency department visits for this 
patient population has increased at an alarming rate. Nationally, hospitals have seen a 70% 
increase in infection-related hospitalizations linked to injection drug use, and an annual increase 
of five percent for hospitalizations related to opioid misuse since 1993 (Trowbridge et al., 2017). 
Patients with SUD are more likely to leave hospital acute care settings AMA when 
compared to the general population (Cortina et al., 2018; Hyshka et al., 2019; McNeil et al., 
2016; Sharma et al., 2017; Ti & Ti, 2015; Trowbridge et al., 2017). Leaving a hospital AMA is 
associated with negative health consequences such as a twofold increase in mortality (Ti & Ti, 
2015), higher hospital readmission rates and increased length of stay (Cortina et al., 2018; 
McNeil et al., 2016; Raven et al., 2011); as well as, increased financial burden for hospital 
systems as noted by Capizzi et al. (2020) with total costs to treat a serious bacterial infection 
related to injection drug use increasing from $16,305,129 in 2008 to $150,879,237 in 2018. 
Research suggests SUD patients leave the acute care setting AMA due to healthcare professional 
biases, stigma (Priest et al., 2020; Sharma et al., 2017; van Boekel et al., 2013), and abstinence-
based hospital policies which lead to undertreated pain and unmanaged withdrawal symptoms 
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Hospital-Based Harm Reduction Interventions 
To improve hospital care experiences, cultural safety, and negative health outcomes 
amongst patients with SUD, research has indicated an urgent need for hospital systems to 
implement harm reduction interventions (McNeil et al., 2016; Sharma et al., 2017; van Boekel et 
al., 2013). Evidence supporting the benefits of utilizing HHRIs is limited, but irrefutable. 
 
SUD Education for De-stigmatization 
Studies have found that healthcare professionals in acute care hospital settings report 
consistently negative attitudes towards SUD patients, and describe an inability, or unwillingness, 
to empathize with this patient population (van Boekel et al., 2013). Provider rationalizations for 
stigmatizations included perceptions that SUD patients are “manipulative, aggressive, rude, and 
poorly motivated” (van Boekel et al., 2013, p. 29). Studies emphasize the importance of SUD-
specific education and training from SUD specialists (i.e., peer support specialists, SUD 
therapists and providers) to combat the stigma felt by this patient population (Priest et al., 2020; 
van Boekel et al., 2013).  
Furthermore, Englander et al. (2020), examined the use of ECHO (Extension for 
Community Healthcare Outcomes) as a distance education tool—provided by one Oregon 
hospital with a SUD program—for urban, rural, and frontier hospitals. Based on a didactic 
curriculum for treatment of patients with a SUD diagnosis, ECHO successfully provided current, 
evidence-based research on treatment modalities for SUD, hospital-based harm reduction 
principles, and provider insight to improve patient-provider relationships and decrease stigma 
associated with SUDs (Englander et al., 2020).  
 
Patient-Centered Care and Motivational Interviewing 
PCC and MI models address the complex needs of SUD patients by underlining the 
importance of subjective assessment data, emphasizing a holistic approach to care, 
acknowledging the patient’s lived experiences (i.e., exploring reasons why a patient started using 
illicit drugs), sharing decision-making power equally, and promoting trusting, positive patient-
provider relationships through communication (Martino et al., 2019; McNeil et al., 2016).  
Studies have highlighted the role of PCC and MI in improving health outcomes of SUD patients 
by decreasing AMA discharges, improving satisfaction with care, and building patient-provider 
rapport (Martino et al., 2019; McNeil et al., 2016).  
 
Medication for Treatment 
The most common HHRI for the recognition and management of complications related to 
OUD (i.e., overdose, withdrawal, pain management) and AUD is the use of provider prescribed 
MFT (Sharma et al., 2017; Trowbridge et al., 2017). MFT for opioid withdrawal includes the use 
of opioid agonist (methadone), partial mu-opioid agonist (buprenorphine), opioid antagonist 
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(naloxone) for detoxification, opioid antagonist (naltrexone) to manage symptoms and cravings 
related to AUD (Trowbridge et al., 2017), and prescription opioids (i.e., injection 
hydromorphone in place of diacetylmorphine, commonly known as heroin; Sharma et al., 2017; 
Trowbridge et al., 2017). In their study, Trowbridge et al. (2017) found that nearly 30% of the 
acute care hospital patients initiated on methadone continued methadone treatment six months 
post-discharge and, 18% of those patients started on buprenorphine continued their OUD 
treatment six months post-discharge. These statistics are promising; however, post six-month 
OUD treatment retention needs further investigation.   
 
The Clinical Opiate Withdrawal Scale (COWS) 
Developed by Wesson and Ling (2003), the COWS is an 11-item tool to measure—
within two minutes—the severity of opioid withdrawal (see Appendix C). Scores range from 
zero to 47, and withdrawal is categorized as mild (five to 12), moderate (13 to 24), moderately 
severe (25 to 36), or severe (greater than 36). Clinical practice guidelines recommend that the 
initiation of buprenorphine should start when patients with OUD experience mild to moderate 
withdrawal; additionally, an initial dose of buprenorphine will not precipitate withdrawals for a 
COWS of 25 or more (Altintoprak et al., 2015; Barbosa-Leiker et al., 2015). Studies have shown 
that the COWS is a critical, reliable, and valid tool for accurate and rapid assessment of opioid 
withdrawal symptoms and clinical management of patients with OUD (Altintoprak et al., 2015; 
Canamo & Tronco, 2019; Tompkins et al., 2009).    
 
Inpatient Addiction Consultations Service (ACS) 
Several studies (Priest et al., 2020; Thompson et al., 2020; Trowbridge et al., 2017; Velez 
et al., 2016; Wakeman et al., 2017) support the use of an inpatient ACSs to improve the 
treatment and care of SUD patients by decreasing stigmatization practices and improving health 
outcomes. Shanahan et al. (2010) found the use of inpatient ACSs reduced the use of illicit drugs 
and alcohol for patients with SUD post-hospitalization: over 80% of discharged SUD patients 
engaged in follow-up addiction treatment appointments, of which, 11% participated in a long-
term recovery program. Furthermore, hospital readmission rates decreased by 75% after SUD 
patients received support from an ACS while hospitalized (Wei et al., 2014). Positive health 
outcomes resulting from the use of an inpatient ACS is echoed by Hyshka et al. (2019) who 
found that some participants had a decrease in the severity of their SUD symptoms post-
discharge, and appreciated the team’s “harm reduction orientation, reputation amongst peers, 
specialized training, and the provision of wraparound health and social supports as key to this 
success” (p. 4). 
 
Discussion 
The findings of this review contribute to a growing literature base on HHRIs, and  
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the care of the SUD patient population. An overview of the research identified four consistent 
themes that inhibited the application of HHRIs, along with practice recommendations that 
facilitate the implementation of HHRIs. These themes include ethical responsibility, stigma, 
structural changes to hospital systems, and noted gaps associated with post-discharge SUD care.  
Findings demonstrate the potential of HHRIs to improve the ethicality of the SUD 
patient-provider relationship by improving treatment pathways, destigmatizing drug use, 
targeting and managing pain and withdrawal symptoms, emphasizing holistic care, and 
addressing racialized inequalities in patient decision making (Cortina et al., 2018; McNeil et al., 
2016; Thompson et al., 2020). A small number of studies show that HHRIs address the ethical 
responsibility and legal obligations of treating a patient with a SUD by prioritizing the subjective 
needs (i.e., withdrawal symptoms) commonly assessed, but often ignored, correlating to 
decreased suffering and AMA discharges (Martino et al., 2019; McNeil et al., 2016).   
Hospitalizations often serve as a motivation for change for individuals who live with a 
SUD due to an increased awareness of mortality, harms associated with substance use, the 
psychosocial damages related to lost relationships made aware from the disruption of drug use, 
and financial costs (Velez et al., 2016). This SUD process insight, along with any potential 
readiness for change, may be lost due to the perceived stigmatizing attitudes of healthcare 
providers towards patients with a SUD. Priest et al. (2020) define stigma as: “the complex of 
attitudes, beliefs, behaviors, and structures that interact at different levels of society (i.e., 
individuals, groups, organizations, systems) and manifest in prejudicial attitudes about and 
discriminatory practices against people with mental and substance use disorders” (p. 60). Studies 
suggest that healthcare professionals exude negative attitudes towards this vulnerable patient 
population due to behavioral challenges (i.e., aggressiveness, manipulation, poor motivation) 
brought on by the biopsychosocial process of SUD (Priest et al., 2020; van Boekel et al., 2013).    
Most evidence denotes that patients with a SUD feel stigmatized in acute care hospital 
settings as a result of their disease (Cortina et al., 2018; Englander et al., 2020; Hyshka et al., 
2019; McNeil et al., 2016; Priest et al., 2020; Sharma et al., 2017; Ti & Ti, 2015; van Boekel et 
al., 2013; Velez et al., 2016); specifically, feelings of dehumanization and poor self-efficacy 
have been reported (Velez et al., 2016; van Boekel et al., 2013) enabling mindsets of mistrust in 
medicine (Thompson et al., 2020). Furthermore, several studies indicate that pervasive stigma 
can lead to suboptimal care resulting in delayed treatment for acute illnesses (Cortina et al., 
2018; van Boekel et al., 2013), distress from untreated or undertreated pain and withdrawal 
symptoms (Hyshka et al., 2019; McNeil et al., 2016), and leaving the hospital AMA without 
completing medical treatment (McNeil et al., 2016; Ti & Ti, 2015; van Boekel et al., 2013). To 
mitigate stigma and improve negative health outcomes, research supports the use of de-
stigmatizing interventions for healthcare professionals like effective education and training 
(Englander et al., 2020; Hyshka et al., 2019; McNeil et al., 2016; Priest et al., 2020; Sharma et 
al., 2017; van Boekel et al., 2013).   
Harm reduction education and training for healthcare professionals needs to be included 
within systematic structural changes. Along with leadership support, organizational policy and 
practices changes within healthcare systems have the potential to improve negative health effects 
of SUD patients by facilitating the implementation of HHRIs (Hyshka et al., 2019). American 
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hospital systems often support abstinence or zero tolerance-based policies for patients with SUD 
(Cortina et al., 2018; Hyshka et al., 2019; McNeil et al., 2016). However, research contradicts 
the use of abstinence-only policies, and favors the use of harm reduction interventions as a more 
cost-effective approach for SUD treatment which does not enable or increase illicit drug use 
(Hawk et al., 2017). Additionally, “[abstinence-based polices] are unrealistic—even in the 
presence of specialized addiction care and effective pain management—because they belie the 
many neurobiological, psychological, social, and environmental factors that contribute to 
ongoing substance use despite exceedingly negative consequences” (Hyshka et al., 2019, p. 5).  
Furthermore, a lack of leadership support for HHRIs is often perceived as a barrier for 
SUD care, often leading to confusion, ambiguity, lack of knowledge, and feelings of opposition 
amongst healthcare professionals (van Boekel et al., 2013). Findings suggest that “hospital 
leaders’ decisions, actions, and attention are critical to supporting evidence-based, 
nondiscriminatory care for people with SUD” (Englander et al., 2020, p. 7). Moreover, formal 
policy changes convey the expectations of HHRI support through consistent recruitment and 
retention practices, new employee training, systemwide mandatory education for healthcare team 
members, and through mentoring by senior staff (Hyshka et al., 2019). Therefore, leadership 
buy-in, stakeholder engagement, and formal policy changes concerning HHRIs can improve 
SUD patient outcomes and experiences while simultaneously decreasing stigma and systemic 
biases.  
A paucity of in-hospital support for HHRIs is not the only perceived barrier for SUD 
patient care. Gaps between post-discharge follow-up care and follow-up with community-based 
SUD treatment programs are a growing concern for this vulnerable patient population (Hyshka et 
al., 2019; Thompson et al., 2020). Findings suggest that HHRIs (e.g., MFTs to manage 
withdrawal symptoms, ACSs) linked with post-discharge follow-up services (i.e., MFT clinics, 
peer support specialists) reduce SUD patient hospital length of stay and increase post-
hospitalization SUD treatment compliance (Trowbridge et al., 2017; Thompson et al., 2020). In 
addition, Trowbridge et al. (2017) found that connecting SUD patients to on-going outpatient 
care is feasible and generalizable for most urban settings.   
 
Limitations 
There are several common limitations of the included studies which should be discussed 
to better contextualize the findings. First, the literature is limited to observational studies, 
qualitative research designs, retrospective analyses, and one randomized control study. 
Therefore, it is difficult to define a clear causal relationship between the explanatory variables 
(HHRIs) and the response variable (improved health outcomes for SUD patients). Forthcoming 
research of higher methodological quality is required to better appreciate the relationship 
between improved health outcomes and use of HHRIs. However, it is important to note the 
unethical nature of randomizing the SUD patient population with regards to treatment of opioid, 
alcohol, amphetamine, and benzodiazepine withdrawal symptoms; thus, future research may be 
restricted to observational studies.   
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Second, most of the studies were completed in environments with well-established harm 
reduction services. In addition, study environments are limited to one location suggesting single 
site limitations. This may limit generalizability as the findings may not be transferable to rural 
hospital settings that lack resources (e.g., funding, SUD specialists, leadership buy-in) imperative 
for implementation. Further studies should continue to investigate the feasibility of HHRIs in 
non-academic, rural, and frontier hospitals.  
Third, some study designs have restricted outcome assessments which may challenge the 
efficacy and validity of select hospital-based harm reduction treatments (i.e., long-term success 
rates of MFTs for OUD). Studies contribute limited follow-up completeness to short-term 
follow-up periods (30 to 180-day post hospital discharge), and reduced participant follow-up 
rates due to common biopsychosocial factors of the SUD patient population: homelessness, 
accessibility to care, and racial disparities. These factors should be considered when designing 
future studies. Longitudinal designs may yield better outcome assessments, strengthening the 
validity of the aforementioned interventions. Federal, state, and city policies and practices 
addressing people experiencing homelessness and SUDs should be implemented with urgency.   
Noted are the intrinsic limitations within this paper. Though the literature was 
systematically searched, it is possible that relevant studies were excluded or not found, and 
publication bias may be present as this paper can only review the research that has been 
published. In addition, search results were limited only to the English language which, 
consequentially, excluded the literature published in languages of countries that commonly 




Despite the limitations, this review has important implications for integrating harm 
reduction interventions within inpatient and outpatient healthcare systems. To address the 
complex care and treatment of SUD patients, organizational policy change will be needed to 
support HHRIs. With the assistance of health professionals, regulatory bodies such as the 
Centers for Disease Control and Prevention (CDC), Centers for Medicare and Medicaid Services 
(CMS), Canadian Society for Addiction Medicine (CSAM), and state-level departments of health 
will be required to update their abstinence-based clinical practices and policies; thus, reflecting 
the harm reduction model’s evidence-based guidelines and expert opinions on SUD care. These 
policy and practice changes may reduce negative health outcomes of the SUD patient population 
by emphasizing PCC; therefore, reducing stigma and improving overall quality of care (Hyshka 
et al., 2019; Nadelmann & LaSalle, 2017; Priest et al., 2020).  
While integrating focused harm reduction methodologies into acute care hospital policies 
and practices has the potential to improve negative health outcomes, a more focused approach, 
such as specialized hospital SUD units, may promote PCC and decrease adverse patient 
outcomes (McNeil et al., 2016; van Boekel et al., 2013). Specialized SUD units may provide a 
necessary culture of safety for not only this patient population, but for the healthcare 
professionals that work in the setting. Research has shown that health professionals who work 
with SUD patients on a more consistent basis express less perceived biases and more tolerance 
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for this patient population (van Boekel et al., 2013). An acute care hospital would have to 
provide the resources and education for healthcare providers through the lens of harm reduction 
principles.  
Hospitalizations present unique socio-emotional challenges to the SUD patient 
population. Peer support specialist provide sponsorship by utilizing harm reduction principles 
and strategies to advocate, support, and educate SUD patients from onset of withdrawal 
symptoms at hospital admittance through treatment options at hospital discharge. Peer supporters 
meet patients where they are at on the recovery spectrum. Their aim is to de-stigmatize the SUD 
patient population and drug use, as well as, to manage the compulsion to use, emotional pain, 
and other unique needs of SUD patients through MI. Studies have shown that the integration of 
peer support specialists into acute hospital settings have improved the SUD patient-provider 
relationship whilst reducing stigma and implicit biases aimed at this marginalized population 
(Velez et al., 2016; Hyshka et al., 2019).  
Moreover, peer support specialists keep SUD patients engaged in care once they leave the 
hospital. They provide a link to a variety of outpatient services (i.e., resources for SUD patients 
with food insecurities, transportation to methadone clinics) for SUD patients. This bridge to 
outpatient services is the source of engagement that improves negative health outcomes for this 




This review provides insight into the challenges related to HHRI development, 
implementation, and sustainability. The findings suggests that HHRIs are a useful treatment 
option to manage the unique needs associated with the growing SUD patient population. HHRIs 
represent a promising approach to improve SUD patient health outcomes, reduce stigma, and 
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Appendix A 
PRISMA 2009 Flow Diagram 
 
From “Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement,” by Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA 
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Appendix B 
Table of Evidence 
Article Author, year Aim Research Design Population/Sample Outcome Time 








Korthuis, P., & 
Menza, T. 
(2020) 









cost of treatment 
for this patient 
population.  





increased from 0.26% 
to 1.68% (P<0.001):  
bacteremia/sepsis rose 
most rapidly with an 
18-fold increase. 
Overall, the total cost of 
hospitalizations 
increased from 
$16,305,129 in 2008 to 









Milloy, M., & 















539 SUD patients  59.4% reported 
willingness to use an in-
hospital supervised 
inhalation room 
highlighting potential of 
supervised inhalation 
rooms to complement 
existing in-hospital 
services for PWUD. 
6/2013-
5/2014 
3 Englander, H., 
Patten, A., 
Lockard, R., 















143 hospital providers 
and administrators in 
the State of Oregon 
67.1% of participants 
were highly satisfied 
with ECHO and more 
prepared to treat SUD. 
1/2019-
1/2020 
4 Hawk, M., 
Coulter, R. S., 
Egan, J. E., 
Fisk, S., Reuel 
Friedman, M., 







a clinic setting, 
and to apply this 
data and principles 




inquiry & research 
design 
23 SUD patients and 
17 staff members of a 
HIV clinic 
Six principles of harm 














Dong, K., & 
Salvalaggio, G. 
(2019) 
To address the gap 
in research on the 
implementation of 
an ACS in acute 
care hospitals. 
Qualitative 
inquiry & research 
design 
21 SUD patients ACS led to better 
hospital experiences 
and perceived outcomes 
for SUD patients.  
6/2015-
5/2016 
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6 Martino, S., 
Zimbrean, P., 
Forray, A., 
Kaufman, J. S., 





R., & Yonkers, 
K. A. (2019) 










RCT 38 providers 
(physicians, PAs, and 
RNs), and 1173 SUD 
patients admitted to 
acute care hospital 
Patients who received 
MI from the ACS 
favored reducing 
substance misuse when 
compared to those 
patients who did not 




7 McNeil, R., 
Kerr, T., Pauly, 
B., Wood, E., 
& Small, W. 
(2016) 
To explore the 
perspectives of 












inquiry & research 
design 
30 PWUD who 
discharged from a 
hospital AMA in last 
two years, and had 
multiple 




for PWUD can 
potentially improve 
hospital care retention, 
promote PCC, and 




8 Nadelmann, E., 
& LaSalle, L. 
(2017) 





within the U.S. 
compared to 
Western Europe 
and other regions. 
Practice guidelines NA Ideological resistance to 
harm reduction is 
fading in the US. The 
U.S. lags behind 





9 Priest, K.C., 
Englander, H., 












inquiry & research 
design 




Six themes that 
promoted or inhibited 
ACS development and 
operations identified.  
NA 
10 Raven, M. C., 
Doran, K. M., 
Kostrowski, S., 
Gillespie, C. C., 
& Elbel, B. D. 
(2011) 









improve care and 
reduce costs. 
Cohort study 19 SUD patients with 
64 inpatient 
admissions to an 
urban acute care 
hospital 
Patients had a total of 
64 inpatient admissions 
in the 12 months before 
the intervention, versus 
40 in the following 12 
months, a 37.5% 
reduction. 73.3% had 
fewer inpatient 
admissions in the year 
after the intervention 
compared to the prior 
year. 
NA 
11 Shanahan, C. 
W., Beers, D., 
Alford, D. P., 
Brigandi, E., & 
Samet, J. H. 
(2010) 
To identify and 




Cohort study 203 people with OUD OUD patients in acute 
care hospitals presented 
with ORT, PCC, MI, 
and principles of harm 
reduction were engaged 
in addiction treatment.  
1/2002-
1/2005 
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H., & Bayoumi, 
A. M. (2017) 




acute care hospital 
settings. 
Practice guidelines NA Evidence is strong for 
harm reduction 
interventions to 
increase positive health 
outcomes; further 
research is needed to 
integrate harm 
reduction strategies into 
acute care hospital 
settings 
NA 
13 Thompson, H. 
M., Faig, W., 
VanKim, N. A., 
Sharma, B., 
Afshar, M., & 
Karnik, N. S. 
(2020) 
To determine if an 
ACS is effective 
at reducing SUD 
patient length of 







health outcomes.  
Cohort study 1,900 SUD patients Length of stay was 
shorter among 
encounters with a SUD 




versus those admissions 
that did not receive one 
(5.77 v. 6.54 days, 
p<0.01). 
2018 
14 Ti, Lianping, 
Ti, Lianlian. 
(2015) 
To examine the 
phenomena of 
SUD patients 




to minimize these 
occurrences. 
Systematic review 17 studies AMA prevalence is 25-
30%; factors positively 
associated with leaving 
AMA include injection 
drug use. Negatively 
affected this outcome 
include ORT, social 
support, and post-
discharge follow-up.  
1977-2014 
15 Trowbridge, P., 
Weinstein, Z. 
M., Kerensky, 
T., Roy, P., 
Regan, D., 
Samet, J. H., & 
Walley, A. Y. 
(2017) 
To describe the 
implementation of 
an ACS at Boston 
Medical Center, 
and rates of 
success for their 
ORT clinic. 
Cohort study 337 SUD patients For methadone, 76% 
linked to methadone 
clinic, with 54%, 39%, 
and 29% still retained at 
30, 90, and 180 days, 
respectively. For 
buprenorphine, 49% 
linked to clinic, with 
39%, 27%, and 18% 
retained at 30, 90, and 
180 days For 
naltrexone, 26% linked 
to clinic, all with 
alcohol UD alone. 
7/2015-
1/2016 
16 van Boekel, L. 
C., Brouwers, 
E. P., van 
Weeghel, J., & 
Garretsen, H. F. 
(2013) 







these attitudes on 
healthcare 
delivery. 
Systematic review 28 studies Negative attitudes (i.e., 
stigma) of health 
professionals towards 
SUD patients are 
common, and contribute 
to negative health 
outcomes. 
2000-2011 
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To explore the 
experiences of 
hospitalized 
adults with SUD 
and to better 
understand patient 





inquiry & research 
design 
32 SUD patients Mortality was 
motivation for change 
and hospitalization 
disrupted substance use. 
Patients experience 
trauma, homelessness, 
and chronic pain, and 
appreciate providers 
who have experience 





18 Wakeman, S. 
E., Metlay, J. 
P., Chang, Y., 
Herman, G. E., 














399 SUD patients ACS reduced addiction 
severity for alcohol and 
drug use, and increased 
the number of days of 
abstinence in the first 








Huen, W., & 
Tulsky, J. 
(2014) 








Case control study 292 SUD patients Rates of MFT increased 




decreased from 23.4 % 
to 8.2 % (p 
value=0.042). All cause 
emergency department 
visits within 30 days of 
discharge decreased 




Note. Abbreviations: PWUD (people who use drugs), ORT (opioid replacement therapy), RCT (randomized control trial), PA (physician 
assistant), RN (registered nurse), and NA (not applicable).
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Appendix C 
Clinical Opiate Withdrawal Scale 
 
Note. From “The Clinical Opiate Withdrawal Scale (COWS),” by D. Wesson & W. Ling, 2003, Journal of Psychoactive Drugs, 35(2), p. 259. 
